Tag Archive

The following is a list of all entries tagged with expanded access program:

Compassionate Use for Investigational Drugs

In the Avelient BioPharm Blog article “A Brief FDA History Lesson“, Mariano Di Fabio provided some background on the events that lead to the establishment of the FDA’s current clinical trial framework, and he questioned if this framework should be changed so that experimental drugs could be released for use by terminally ill patients.  Mariano [...]